Results of what has been studied are promising. CBD has many benefits, such as anti-inflammatory and neuroprotective properties.

Some studies have found CBD may be effective in providing relief from various mental health conditions, including:
- Anxiety disorders
- Post-traumatic stress disorder (PTSD)
- Addiction
- Schizophrenia
It may be effective for physical conditions as well. Likewise, CBD has also been proven to help treat childhood epilepsy and other seizure disorders. Some evidence points to CBD’s anticancer properties and benefits in managing the side effects of cancer treatment.
More research is needed to determine the benefits of using CBD as a treatment for mental and physical health conditions.
Overview of diseases for which CBD may have therapeutic benefits.
Disease | Effects |
Alzheimer’s disease | Anti Inflammatory, antioxidant, antiapoptotic in in vitro and in vivo models of Aβ-evoked neuroinflammatory and neurodegenerative responses. |
Parkinson’s disease | Attenuation of the dopaminergic impairment in vivo; neuroprotection; improvement of psychiatric rating and reduction of agitation, nightmares and aggressive behaviour in patients. |
Multiple sclerosis | Improved signs of EAE in mice, anti-inflammatory and immunomodulatory properties. |
Huntington’s disease | Neuroprotective and antioxidant in mice transgenic models; no significant clinically important differences in patients. |
Hypoxia-ischemia injury | Short term neuroprotective effects; inhibition of excitotoxicity, oxidative stress and inflammation in vitro and in rodent models. |
Pain | Analgesic effect in patients with neuropathic pain resistant to other treatments. |
Psychosis | Attenuation of the behavioural and glial changes in animal models of schizophrenia; antipsychotic properties on ketamine-induced symptoms |
Anxiety | Reduction of muscular tension, restlessness, fatigue, problems in concentration, improvement of social interactions in rodent models of anxiety and stress; reduced social anxiety in patients. |
Depression | Antidepressant effect in genetic rodent model of depression. |
Cancer | Antiproliferative and anti-invasive actions in a large range of cancer types; induction of autophagy-mediated cancer cell death; chemopreventive effects. |
Nausea | Suppression of nausea and conditioned gaping in rats |
Inflammatory diseases | Anti-inflammatory properties in several in vitro and in vivo models; inhibition of inflammatory cytokines and pathways. |
Rheumatoid arthritis | Inhibition of TNF-α in an animal model |
Infection | Activity against methicillin-resistant Staphylococcus aureus |
Inflammatory bowel and Crohn’s diseases | Inhibition of macrophage recruitment and TNF-α secretion in vivo and ex vivo; reduction in disease activity index in Crohn’s patients. |
Cardiovascular diseases | Reduced infarct size through antioxidant and anti-inflammatory properties in vitro and in vivo. |
Diabetic complications | Attenuation of fibrosis and myocardial dysfunction |